New Technologies on the Horizon
•Watson
app by Medtronic
•YoFi
Meter
•VisioMed's
Bewell Connect App + Meter
•Lumee
Body Chemistry Biosensor
•DietSensor,
Made by D-Parents
•Quell
for Diabetic Neuropathy
|
|
|
|
There
are several new products
coming to market in the next couple of years that
will help people with diabetes. The trend is toward
delivering more information to the patient and the
healthcare team with the emphasis on having patients
take a more active role in the own healthcare. These
technologies are now all somewhere between the
prototype stage and finished product newly on the
market.
Watson app by Medtronic
This app has the capability to predict
hypoglycemia three hours in advance of its
occurrence. It will synthesize information from
Medtronic insulin pumps and CGM devices.
YoFi Meter
This device allows patients to wirelessly transmit
their blood sugar results plus "other biometric data
and voice notes" to providers and caregivers using
AT&T’s network. The device takes a blood sample and
transmits it all with one press of a button. This
allows for near real-time monitoring of blood
glucose levels by the healthcare team.
VisioMed's Bewell Connect App + Meter
This combination of a smartphone app with a blood
glucose meter or other select devices (a glucose
meter, thermostat, blood pressure monitor, and blood
oxygen sensor are all slated to become available) is
being touted as a “virtual checkup” toolset, but it
goes beyond that by allowing the user to share the
data with a physician just by pushing a button on
the mobile app.
Lumee Body Chemistry Biosensor
A single sensor attached to the body continuously
monitors a variety of body chemistry stats,
including glucose and oxygen levels, heart rate,
respiration and more, and securely transmit the data
anywhere via the smartphone app.
DietSensor, Made by D-Parents
This device uses SCiO,
a molecular sensor that determines the chemical
makeup of food or drinks by analyzing how the
molecules interact using light. To use the
DietSensor, the small scanner (about the size of a
pager) is held over the food while it takes a photo
and transmits that to the smartphone DietSensor app
to judge the volume. Then DietSensor reports back
with the nutritional value of the food scanned based
on the information stored in its database.
Quell for Diabetic Neuropathy
Massachusetts company NeuroMetrix announced FDA
approval of its second-generation pain relief
wearable device Quell. This device alleviates
chronic pain through neural pulses — delivered by a
band wrapped just below the knee
and
a companion app allows users to change settings and
track sessions using their smartphone. It has been
clinically proven to start relieving chronic pain in
as little as 15 minute by stimulating nerves and
blocking pain signals in the body.
Summary
We have seen that the three types of diabetic
neuropathy are major contributors in the development
of a diabetic foot wound. Although the threat of
wounding and the potential for amputation is ever
present, we have shown that with proper care and
education, the correct use of offloading devices,
and appropriate product selection diabetic foot
wounds can be managed effectively. Many options
are available to the care team when treating
diabetic foot wounds. Proper therapy selection, used
appropriately and at the right time, can make the
difference between the patient heading down the road
toward amputation, or to appropriate and timely
wound healing. Early intervention is key, with the
emphasis on patient self-analysis
and intervention coupled with an integrated
healthcare team, being
the first step.
That concludes our presentation, and it’s time to
take the course evaluation and post-test. The
organizations that provide this course’s continuing
education accreditations, and your credits for this
course, require each of you to fill out a course
evaluation and to pass the post-test with eight or
more correct answers in order to receive CE credit.